DexCom Aktie
WKN: A0D9T1 / ISIN: US2521311074
25.10.2024 23:53:25
|
Why DexCom Stock Flopped on Friday
The stock of highly specialized healthcare company DexCom (NASDAQ: DXCM) wasn't the picture of health on Friday. It lost nearly 2% of its value in that day's trading session, on the back of an earnings release that raised investor concerns about slowing sales growth. The S&P 500 index outperformed the stock, and that's not saying much, as it essentially ended the day flat over Thursday.Reporting its third-quarter results after market hours Thursday, DexCom said its revenue amounted to $994 million for the period. This was, however, only 2% higher on a year-over-year basis for the previously fast-growing glucose monitoring products specialist. Non-GAAP (adjusted) net income fell to slightly over $181 million ($0.45 per share) from the year-ago figure of $204 million. According to Zack's, the consensus analyst estimate for profitability was $0.43. Meanwhile, DexCom only marginally topped the average prognosticator projection for revenue. Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DexCom Inc.mehr Nachrichten
01.04.25 |
Gewinne in New York: NASDAQ 100 mit Gewinnen (finanzen.at) | |
01.04.25 |
NASDAQ Composite Index-Papier DexCom-Aktie: So viel hätten Anleger mit einem Investment in DexCom von vor 3 Jahren verloren (finanzen.at) | |
27.03.25 |
Schwacher Handel: NASDAQ 100 zeigt sich zum Handelsende leichter (finanzen.at) | |
25.03.25 |
Freundlicher Handel in New York: So performt der NASDAQ 100 aktuell (finanzen.at) | |
25.03.25 |
NASDAQ 100 aktuell: NASDAQ 100 mittags auf grünem Terrain (finanzen.at) | |
25.03.25 |
NASDAQ Composite Index-Wert DexCom-Aktie: So viel hätten Anleger an einem DexCom-Investment von vor einem Jahr verloren (finanzen.at) | |
21.03.25 |
NASDAQ-Handel NASDAQ 100 in Rot (finanzen.at) | |
21.03.25 |
Gewinne in New York: NASDAQ 100 am Mittag im Aufwind (finanzen.at) |
Analysen zu DexCom Inc.mehr Analysen
Aktien in diesem Artikel
DexCom Inc. | 54,61 | -2,19% |
|